Cambridge Investment Research Advisors’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-23,953
| Closed | -$863K | – | 3635 |
|
|
2024
Q4 | $863K | Buy |
23,953
+10,286
| +75% | +$371K | ﹤0.01% | 1987 |
|
|
2024
Q3 | $580K | Buy |
13,667
+679
| +5% | +$28.8K | ﹤0.01% | 2289 |
|
|
2024
Q2 | $523K | Sell |
12,988
-300
| -2% | -$12.1K | ﹤0.01% | 2264 |
|
|
2024
Q1 | $471K | Buy |
+13,288
| New | +$471K | ﹤0.01% | 2328 |
|
|
2023
Q2 | – | Sell |
-6,388
| Closed | -$259K | – | 3290 |
|
|
2023
Q1 | $259K | Buy |
6,388
+160
| +3% | +$6.49K | ﹤0.01% | 2609 |
|
|
2022
Q4 | $280K | Buy |
6,228
+49
| +0.8% | +$2.2K | ﹤0.01% | 2485 |
|
|
2022
Q3 | $296K | Buy |
6,179
+300
| +5% | +$14.4K | ﹤0.01% | 2370 |
|
|
2022
Q2 | $348K | Sell |
5,879
-640
| -10% | -$37.9K | ﹤0.01% | 2246 |
|
|
2022
Q1 | $758K | Sell |
6,519
-500
| -7% | -$58.1K | ﹤0.01% | 1787 |
|
|
2021
Q4 | $1.06M | Buy |
7,019
+55
| +0.8% | +$8.28K | ﹤0.01% | 1545 |
|
|
2021
Q3 | $831K | Sell |
6,964
-200
| -3% | -$23.9K | ﹤0.01% | 1677 |
|
|
2021
Q2 | $698K | Sell |
7,164
-727
| -9% | -$70.8K | ﹤0.01% | 1797 |
|
|
2021
Q1 | $696K | Buy |
7,891
+331
| +4% | +$29.2K | ﹤0.01% | 1663 |
|
|
2020
Q4 | $723K | Buy |
7,560
+4,248
| +128% | +$406K | ﹤0.01% | 1521 |
|
|
2020
Q3 | $376K | Buy |
3,312
+331
| +11% | +$37.6K | ﹤0.01% | 1783 |
|
|
2020
Q2 | $295K | Buy |
+2,981
| New | +$295K | ﹤0.01% | 1899 |
|
|
2019
Q4 | – | Sell |
-10,181
| Closed | -$600K | – | 2474 |
|
|
2019
Q3 | $600K | Buy |
10,181
+151
| +2% | +$8.9K | 0.01% | 1379 |
|
|
2019
Q2 | $647K | Sell |
10,030
-2,538
| -20% | -$164K | 0.01% | 1275 |
|
|
2019
Q1 | $798K | Buy |
+12,568
| New | +$798K | 0.01% | 1168 |
|
|
2018
Q4 | – | Sell |
-10,260
| Closed | -$440K | – | 2282 |
|
|
2018
Q3 | $440K | Buy |
+10,260
| New | +$440K | ﹤0.01% | 1526 |
|